CompaniesByCap
BTMD
Biote Corp. (BTMD)
NASDAQ · Healthcare

Biote Corp. Revenue 2021–2025

Biote Corp. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Biote Corp. revenue for the quarter ending March 31, 2026 was 44.9 M, a 8.28% decrease year-over-year.
  • Biote Corp. revenue for the twelve months ending March 31, 2026 was 190.7 M, a 1.12% decrease year-over-year.
  • Biote Corp. annual revenue for 2025 was 192.2 M, a 2.52% decrease from 2024.
  • Biote Corp. annual revenue for 2024 was 197.2 M, a 6.38% increase from 2023.
  • Biote Corp. annual revenue for 2023 was 185.4 M, a 12.37% increase from 2022.
  • Biote Corp. annual revenue for 2022 was 165.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Biote Corp. (BTMD) — Frequently Asked Questions

Biote Corp. (BTMD) is a publicly traded US company. It has a market capitalization of $86M. In fiscal 2025 it reported revenue of $192M and net income of $27M. Explore BTMD's stock price, financial statements, earnings history, margins and key ratios below.

What is Biote Corp.'s market cap?

Biote Corp. (BTMD) has a market capitalization of $86M.

What is the BTMD stock price?

BTMD trades at $2.35 (+3.74% on the day).

How much revenue does Biote Corp. make?

Biote Corp. reported revenue of $192M in fiscal 2025.

Is BTMD profitable?

In fiscal 2025, Biote Corp. reported net income of $27M.